Erlotinib (OSI-774, Tarceva™), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Chemotherapy for Advanced Non–Small-Cell Lung Cancer
2003 ◽
Vol 4
(6)
◽
pp. 336-338
◽
2010 ◽
Vol 28
(28)
◽
pp. e507-e510
◽
2016 ◽
Vol 24
(5)
◽
pp. 263-279
◽